|
| H2N-PEG6-CH2COOtBu Basic information |
Product Name: | H2N-PEG6-CH2COOtBu | Synonyms: | H2N-PEG6-CH2COOtBu;NH2-PEG6-C1-Boc;NH2CH2CH2(OCH2CH2)5OCH2CO2-t-Bu;NH2-PEG6-CH2COOtBu;tert-butyl 20-amino-3,6,9,12,15,18-hexaoxaicosanoate;NH-2-PEG6-C1-Boc,PROTAC Linkers,Inhibitor,NH2 PEG6 C1 Boc,inhibit,NH2PEG6C1Boc;H2N-PEG6-CH2COOtBu/3,6,9,12,15,18-Hexaoxaeicosanoic acid, 20-amino-, 1,1-dimethylethyl ester;3,6,9,12,15,18-Hexaoxaeicosanoic acid, 20-amino-, 1,1-dimethylethyl ester | CAS: | 297162-50-6 | MF: | C18H37NO8 | MW: | 395.48828 | EINECS: | | Product Categories: | | Mol File: | 297162-50-6.mol | |
| H2N-PEG6-CH2COOtBu Chemical Properties |
Boiling point | 463.4±40.0 °C(Predicted) | density | 1.065±0.06 g/cm3(Predicted) | pka | 8.74±0.10(Predicted) |
| H2N-PEG6-CH2COOtBu Usage And Synthesis |
Biological Activity | NH2-PEG6-C1-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. | References | [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 |
| H2N-PEG6-CH2COOtBu Preparation Products And Raw materials |
|